Dr. Langer Discusses the Impact of Targeted Therapy in NSCLC
Dr. Langer Discusses the Impact of Targeted Therapy in NSCLC
May 15, 2019
onclive.com
Mutation Testing to Guide ALK TKI Selection in NSCLC
Mutation Testing to Guide ALK TKI Selection in NSCLC
Jan 31, 2017
onclive.com
Treatment Strategy of ROS1-Rearranged NSCLC in TKI-Naive Patient
Treatment Strategy of ROS1-Rearranged NSCLC in TKI-Naive P…
1 year ago
reachmd.com
Treatment of TKI-Refractory EGFR-Mutant NSCLC
Treatment of TKI-Refractory EGFR-Mutant NSCLC
2K viewsNov 12, 2021
onclive.com
Dr. Goldberg Discusses Resistance to EGFR TKI Therapy in NSCLC
Dr. Goldberg Discusses Resistance to EGFR TKI Therapy in NSCLC
Mar 8, 2018
onclive.com
A Retrospective Look at ALK-Rearranged NSCLC Management
A Retrospective Look at ALK-Rearranged NSCLC Management
Feb 4, 2020
onclive.com
Dacomitinib: Dark Horse EGFR TKI Charges into First Line Setting for Advanced NSCLC
Dacomitinib: Dark Horse EGFR TKI Charges into First Line Setting fo…
142 viewsMay 20, 2020
vumedi.com
Choosing Second-Line Therapy for ALK NSCLC
Jan 31, 2017
onclive.com
The Importance of NGS Testing in NSCLC
Mar 30, 2020
onclive.com
The Importance of Targeting RET in NSCLC
Mar 30, 2020
onclive.com
Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Followin…
Oct 6, 2023
onclive.com
Immuno- and Chemotherapy Approach to R/R NSCLC
Feb 4, 2020
onclive.com
Unmet Needs in NSCLC Treatment
Jun 22, 2022
ajmc.com
How Much Tissue Do You Need for NSCLC Diagnosis?
May 25, 2018
onclive.com
NSCLC: Consolidation Immunotherapy in Practice
Mar 13, 2018
onclive.com
Multikinase TKIs for NSCLC and Medullary Thyroid Cancer
Oct 18, 2019
onclive.com
Sequencing Therapies in ALK NSCLC
Apr 27, 2017
onclive.com
Treating Newly Diagnosed ALK NSCLC
Jan 14, 2019
onclive.com
Future Directions for ALK NSCLC
Jan 31, 2017
onclive.com
Approaches to Biomarker Testing in NSCLC
Sep 12, 2022
onclive.com
Adverse Events Associated With TKIs in HER2-Mutated NSCLC
10 months ago
onclive.com
Managing ALK-Positive NSCLC Disease Progression
Feb 4, 2020
onclive.com
Clinical Management of NTRK Advanced NSCLC
Nov 8, 2021
onclive.com
When to Conduct Molecular Testing in NSCLC
4 months ago
onclive.com
Dr. Clarke Compares TKIs in EGFR NSCLC
May 29, 2019
onclive.com
6:55
The State of Targeted Therapies in NSCLC
Nov 30, 2023
onclive.com
EGFR-Targeted TKIs in NSCLC and Cost
Aug 23, 2021
onclive.com
Challenges Associated with Molecular Testing in NSCLC
Apr 19, 2022
onclive.com
Emerging ALK/ROS1 TKIs for NSCLC
Jan 31, 2017
onclive.com
Treatment Options for Patients with ALK NSCLC who Progress on Firs…
Dec 8, 2021
targetedonc.com
Static thumbnail place holder